Physiological Saline Market Size Report | Share Forecasts to 2030
[Research Report] The physiological saline market size is expected to grow from US$ 5,522.17 million in 2022 to US$ 9,057.04 million by 2030. The market is estimated to register a CAGR of 6.4% from 2022 to 2030.
Analyst’s Viewpoint
The physiological saline market analysis explains growth drivers such as the rising prevalence of serious illnesses and fluid electrolyte disorders, and surging demand for fluid electrolytes in the elderly population. Further, large-scale saline solution requirements in hospital settings are expected to emerge as new trends in the market during 2022–2030. The physiological saline market, by type, is segmented into normal saline, hypertonic saline, hypotonic saline, and balanced saline. The normal saline segment held the largest market share in 2022. However, hypertonic saline segment is anticipated to register the highest CAGR during 2022–2030. The physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held the largest market share in 2022. The flexible bag segment is anticipated to register the highest CAGR during 2022–2030. The physiological saline market, by application, is segmented as intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. The intravenous segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030. The physiological saline market, by route of administration, is categorized into intravenous and topical. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030. The physiological saline market, by end user, is segmented into hospitals, specialty clinics, ambulatory surgical centers, home care, and others. The hospitals segment held the largest market share in 2022. The specialty clinics segment is anticipated to register the highest CAGR during 2022–2030.
A physiological saline solution is composed of salt solutions that are isotonic and have the same pH. An example of a physiological saline solution is Ringer's solution, composed of a mixture of sodium chloride (NaCl), sodium bicarbonate, and potassium chloride solution. A physician recommends the administration of a physiological solution to treat cases of dehydration, fluid imbalance, and many other similar clinical abnormalities.
Market Insights
Rising Prevalence of Serious Illnesses and Fluid Electrolyte Disorders Propels Physiological Saline Market
People with serious illnesses often experience a profound loss of independence, time, and capabilities. The emotional, physical, and financial toll can be life-altering for people suffering from distress in addition to physical symptoms with specific mental conditions. According to statistics revealed by the Commonwealth Fund report, 62% of people with serious illness experience anxiousness, confusion, or helplessness. 48% have emotional or psychological problems caused by the condition, and 32% report feeling left out, lacking companionship, and isolated from others. A report by the National Health Council reveals that incurable and ongoing chronic diseases affect nearly 133 million Americans, which represents more than 40% of the total population of the country. Among these, almost 50% of all adults and nearly 8% of children aged 5–17 have a chronic condition. The National Health Council’s report also mentions that the increasing cases of incurable chronic diseases among Americans result in ~75% of the healthcare costs.
Serious illnesses result in an imbalance in body fluids, such as low levels of potassium, magnesium, calcium, and sodium in the body. Improper levels of body fluids negatively impact the body's function, muscle strength, and heart rhythm, which is associated with disorders of kidneys or endocrine glands. For example, edema occurs when the body retains excessive fluid levels, resulting in swelling and pain in the face, arms, legs, hands, and feet of patients. Further, losing more body fluids than consumed quantities results in dehydration, which eventually leads to symptoms such as thirst, weakness, lightheadedness, fainting, and decreased urine output among patients. Therefore, chronic illnesses may result in body fluid imbalance in the patient's body, which propels the demand for physiological saline that is administered as a part of their treatment. Thus, the rising prevalence of serious illnesses and fluid electrolyte disorders bolsters the physiological saline market growth.
Future Trend
Large-Scale Saline Solution Requirements in Hospital Settings
According to a report published by the Royal Society of Chemistry, using saline solution for washing red blood cells (RBCs) and treating critically ill patients is a common practice in hospital settings. Clinical research groups have reviewed the safety of using physiological saline (0.9% NaCl) in different clinical settings and suggested that the use of saline solution is one of the safest techniques in hospital settings. For example, in transfusion medicine, saline solution is used for washing cells and salvaging procedures in cases of apheresis and the resuscitation of patients with blood or fluid loss. Washing of RBCs requires 1–2 L of sterile saline solution. In the apheresis procedure, saline solution is used in therapeutic plasma exchange procedures and intra-operative cell salvaging to wash RBCs. Therefore, the multifaceted application of physiological saline on large scales in hospital settings is likely to emerge as a new trend in the physiological saline market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Physiological Saline Market: Strategic Insights
Market Size Value in US$ 5,522.17 million in 2022 Market Size Value by US$ 9,057.04 million by 2030 Growth rate CAGR of 6.4% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Physiological Saline Market: Strategic Insights
Market Size Value in | US$ 5,522.17 million in 2022 |
Market Size Value by | US$ 9,057.04 million by 2030 |
Growth rate | CAGR of 6.4% from 2022 to 2030 |
Forecast Period | 2022-2030 |
Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystReport Segmentation and Scope
Type-Based Insights
The physiological saline market, by type, is segmented into normal saline, hypertonic saline, hypotonic saline, and balanced saline. The normal saline segment held the largest market share in 2022; hypertonic saline segment is anticipated to register the highest CAGR during 2022–2030. Normal saline (NS) comprises a sterile salt solution used for short-term fluid replacement, as it helps restore electrolyte/salt levels in the body. It is a 0.9% sodium chloride solution intended to treat dehydration and electrolyte disturbances among people. NS is a cornerstone of intravenous solutions that are used commonly in clinical settings. It is suitable for both pediatric and adult patient populations. Primary indications for the use of NS solutions approved by the US Food and Drug Administration (FDA) are mentioned below:
- Extracellular fluid replacement to treat dehydration, hypovolemia, hemorrhage, sepsis, etc.
- Treatment of metabolic alkalosis in the presence of fluid loss
- Mild sodium depletion
Further, NS can only be administered through intravenous access, and the management of normal saline requires evaluation of the patient's health status. Pharmacists need to monitor the implementation of IV fluids while installing in the hospitals.
Packaging Type-Based Insights
The physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held the largest market share in 2022. The flexible bags segment is anticipated to register the highest CAGR during 2022–2030. Sodium chloride (NaCl) USP solutions for injections are sterile and nonpyrogenic. They are parenteral solutions that contain various concentrations of NaCl in water for injection (WFI) intended for intravenous (IV) administration. Further, the flexible container is fabricated from a specially formulated polyvinyl chloride. However, solutions stored in plastic containers might trigger the leaching of certain chemical components from the plastic in tiny amounts. Nonetheless, the safety of plastic container materials can be tested effectively through biological evaluation methods. The plastic bottles segment is expected to account for the smallest share of the physiological saline market during the forecast period.
Application-Based Insights
The physiological saline market, by application, is segmented as intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. The intravenous segment held the largest market share in 2022. It is further anticipated to register the highest CAGR during 2022–2030. Intravenous (IV) saline solutions are formulated for the prevention or treatment of dehydration. IV saline is prescribed by physicians for people who are injured, sick, dehydrated, or undergoing surgery, irrespective of their age. Saline IV bags provide a rapid and targeted solution to replenish fluids and relieve symptoms. Furthermore, a combination of sterile water and sodium chloride, or salt and normal saline IVs, helps restore fluid balance and hydrate tissues among patients. IV saline is commonly administered directly into patients’ bloodstreams when they require hydration. It is considered a suitable option for people with allergies or sensitivities to specific medications.
Various companies are offering innovative IV saline products; for example, Fresenius Kabi USA offers "freeflex" and "freeflex+ IV bags." These products also provide leak prevention, sterility protection, and needle-stick prevention.
Route of Administration-Based Insights
The physiological saline market, by route of administration, is categorized into intravenous and topical. The intravenous segment held the largest market share in 2022. The market for this segment is anticipated to register the highest CAGR during 2022–2030. IV saline solutions are specially formulated liquids that are injected into a vein to prevent and treat dehydration. Also, these IV fluids are utilized among people of all ages suffering from sickness, injury, dehydration, etc. The IV saline solution is administered via a simple and safe procedure that is associated with a low risk of complications. Also, fluid resuscitation is a vital component for the management of acutely ill patients, and normal saline is considered to be the most widely used IV fluid for seriously ill or injured patients. Being a common, simple, and safe procedure, patients administered via the IV route may feel relief in a short span.
Physiological Saline Market Report Scope
Regional Analysis
Asia Pacific is expected to register the highest CAGR in the global physiological saline market during 2022–2030. The market in Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China holds the largest share of the physiological saline market in Asia Pacific. The physiological saline market growth in China during 2020–2030 is ascribed to the rising chronic disease incidences. According to the National Health Commission of the People's Republic of China, more than 300 million patients have been diagnosed with chronic diseases, accounting for 86.6% of the total chronic disease deaths. China also reports the second-highest number of tuberculosis (TB) cases. In 2020, nearly 842,000 people were diagnosed with TB in China, as per the statistics revealed by the Centers for Disease Control and Prevention (CDC). Likewise, chronic diseases among the patients have resulted in accelerated demand for physiological saline. The UCLA Health 2023 report reveals that the medical community understood the role of dietary science and nutrition in chronic disease progression. Therefore, simple strategies such as reducing sodium intake as well as minimizing added refined sugar and saturated fat consumption can help prevent diet-associated illnesses and promote overall wellness. This nutritional content is supplied through a physiological saline solution comprising salts (sodium and potassium), sugars (carbohydrates and glucose), plant-based and animal-source diets, water intake for wellness, coffee and tea, fruit juice or soda, and so on.
The report profiles leading players operating in the physiological saline market. These include Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Packaging Type, Application, Route of Administration, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The physiological saline market majorly consists of the players such Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science, and amongst others.
Global physiological saline market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the physiological saline market in 2022.
Fresenius Kabi AG and B Braun Medical Inc are the top two companies that hold huge market shares in the physiological saline market.
Physiological saline is a 0.9% sodium chloride (NaCl) solution referred to as "physiological" containing isotonic solution with an osmotic pressure equivalent to that of body fluids under normal conditions. To create physiological saline, people dissolve 9g of pure salt with 1 liter of distilled water. Currently, physiological saline has dosage forms such as bottles of solution for infusion, physiological saline eye drops, nose drops, and ear drops, usually available in the form of 100ml, 250ml, and 500ml.
The normal saline segment held the largest share of the market in the global physiological saline market in 2022.
The CAGR value of the physiological saline market during the forecasted period of 2022-2030 is 6.4%.
The intravenous (IV) segment dominated the global physiological saline market and held the largest market share in 2022.
Key factors that are driving the growth of this market are rising prevalence of serious illnesses and fluid electrolytes disorders and surging demand for fluid electrolytes in ageing population are expected to boost the market growth for the physiological saline over the years.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Physiological Saline Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Physiological Saline Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Physiological Saline Market - Global Market Analysis
6.1 Physiological Saline - Global Market Overview
6.2 Physiological Saline - Global Market and Forecast to 2030
7. Physiological Saline Market – Revenue Analysis (USD Million) – By Product, 2020-2030
7.1 Overview
7.2 Intravenous
7.3 Topical
7.3.1 Eye Drops
7.3.2 Nose Drops
7.3.3 Ear Drops
7.3.4 and Others
8. Physiological Saline Market – Revenue Analysis (USD Million) – By Packaging Type, 2020-2030
8.1 Overview
8.2 Flexible Bag
8.3 Plastic Bottles
8.4 Glass Bottles
9. Physiological Saline Market – Revenue Analysis (USD Million) – By Application, 2020-2030
9.1 Overview
9.2 Acute Health Condition
9.3 Chronic Diseases
9.4 Skin Abrasion and Wound Care
9.5 Others
10. Physiological Saline Market – Revenue Analysis (USD Million) – By End User, 2020-2030
10.1 Overview
10.2 Hospitals and Specialty Clinics
10.3 Ambulatory Surgical Centers
10.4 Others
11. Physiological Saline Market – Revenue Analysis (USD Million) – By Saline Type, 2020-2030
11.1 Overview
11.2 Normal Saline
11.3 Hypertonic Saline
11.4 Hypotonic Saline
12. Physiological Saline Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
12.1 North America
12.1.1 North America Physiological Saline Market Overview
12.1.2 North America Physiological Saline Market Revenue and Forecasts to 2030
12.1.3 North America Physiological Saline Market Revenue and Forecasts and Analysis - By Product
12.1.4 North America Physiological Saline Market Revenue and Forecasts and Analysis - By Packaging Type
12.1.5 North America Physiological Saline Market Revenue and Forecasts and Analysis - By Application
12.1.6 North America Physiological Saline Market Revenue and Forecasts and Analysis - By End User
12.1.7 North America Physiological Saline Market Revenue and Forecasts and Analysis - By Saline Type
12.1.8 North America Physiological Saline Market Revenue and Forecasts and Analysis - By Countries
12.1.8.1 United States Physiological Saline Market
12.1.8.1.1 United States Physiological Saline Market, by Product
12.1.8.1.2 United States Physiological Saline Market, by Packaging Type
12.1.8.1.3 United States Physiological Saline Market, by Application
12.1.8.1.4 United States Physiological Saline Market, by End User
12.1.8.1.5 United States Physiological Saline Market, by Saline Type
12.1.8.2 Canada Physiological Saline Market
12.1.8.2.1 Canada Physiological Saline Market, by Product
12.1.8.2.2 Canada Physiological Saline Market, by Packaging Type
12.1.8.2.3 Canada Physiological Saline Market, by Application
12.1.8.2.4 Canada Physiological Saline Market, by End User
12.1.8.2.5 Canada Physiological Saline Market, by Saline Type
12.1.8.3 Mexico Physiological Saline Market
12.1.8.3.1 Mexico Physiological Saline Market, by Product
12.1.8.3.2 Mexico Physiological Saline Market, by Packaging Type
12.1.8.3.3 Mexico Physiological Saline Market, by Application
12.1.8.3.4 Mexico Physiological Saline Market, by End User
12.1.8.3.5 Mexico Physiological Saline Market, by Saline Type
Note - Similar analysis would be provided for below mentioned regions/countries
12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 Spain
12.2.5 United Kingdom
12.2.6 Rest of Europe
12.3 Asia-Pacific
12.3.1 Australia
12.3.2 China
12.3.3 India
12.3.4 Japan
12.3.5 South Korea
12.3.6 Rest of Asia-Pacific
12.4 Middle East and Africa
12.4.1 South Africa
12.4.2 Saudi Arabia
12.4.3 U.A.E
12.4.4 Rest of Middle East and Africa
12.5 South and Central America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest of South and Central America
13. Pre and Post Covid-19 Impact
14. Industry Landscape
14.1 Mergers and Acquisitions
14.2 Agreements, Collaborations, Joint Ventures
14.3 New Product Launches
14.4 Expansions and Other Strategic Developments
15. Competitive Landscape
15.1 Heat Map Analysis by Key Players
15.2 Company Positioning and Concentration
16. Physiological Saline Market - Key Company Profiles
16.1 Enzo Life Sciences, Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
Note - Similar information would be provided for below list of companies
16.2 B. Braun
16.3 Grifols, S.A
16.4 Merck KGaA
16.5 Geno Technology Inc.
16.6 Ward's Science
16.7 LABORATORIOS ERN S.A.
16.8 Innaxon
16.9 Adipogen Life Sciences
16.10 Fresenius Kabi
16.11 Baxter
16.12 Pfizer Inc.
16.13 Otsuka Pharmaceutical
16.14 ICU Medical
16.15 Cardinal Health, Inc.
17. Appendix
17.1 Glossary
17.2 About The Insight Partners
17.3 Market Intelligence Cloud
The List of Companies - Physiological Saline Market
- Fresenius Kabi AG
- Merck KGaA
- AdipoGen Life Sciences Inc
- Enzo Life Sciences Inc
- ICU Medical Inc
- Grifols SA
- Geno Technology Inc
- B Braun Medical Inc
- Pfizer Inc
- Ward's Science
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Physiological Saline Market
Dec 2023
Infectious Disease Therapeutics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti Bacterial, Anti-Fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others),  and Geography
Dec 2023
Clinic Casting and Splinting Products Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product [Casting (Casts, Tapes, Cutters, and Casting Accessories) and Splinting (Splints and Splinting Accessories)], Application (Acute Fractures or Sprains, Tendon and Ligament Injuries, and Others), Material (Plaster of Paris, Fiberglass, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2023
Myopia Treatment Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (High Myopia, Degenerative Myopia, Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Ortho-K, Contact Lenses, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers), and Geography
Dec 2023
Epilepsy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Dec 2023
Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography
Dec 2023
Human Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography
Dec 2023
Epilepsy Drugs Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (First-Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Dec 2023
Specialty Hospitals Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Specialty Type (Pediatric Hospitals, Obstetrics-Gynecology Hospitals, ENT Hospitals, Oncology Hospitals, Rehabilitation Hospitals, Orthopedic Hospitals, Neurology Hospitals, Cardiology Hospitals, IVF Hospitals and Others), Service Type (Outpatient and Inpatient), Hospital Type (Public Hospitals and Private Hospitals), and Geography (North America, Europe, Asia Pacific, and Middle East & Africa)